KNEE OSTEOARTHRITIS TREATMENT
GenVisc 850 Injection Knee Pain Relief
GenVisc® 850 hyaluronic acid injections help relieve knee osteoarthritis pain for patients who haven't found relief from physical therapy or basic pain medication. Elite Ortho offers GenVisc® 850 through your insurance or a self-pay Direct Access path — whichever fits your coverage and your timeline.
Clinically proven
2–3 week access
No authorization
Clinically Tested
30+ Clinical Studies
Used Worldwide
Safe & Repeatable
Physician-Administered
What is GenVisc?
A Clinically Studied Joint Treatment
GenVisc® 850 is a hyaluronic acid (HA) injection, also called a viscosupplement, used to relieve pain caused by knee osteoarthritis. It's typically considered for patients who haven't gotten enough relief from physical therapy, activity modification, or over-the-counter pain medication.
At Elite Ortho, GenVisc® 850 is one of several hyaluronic acid (HA injections) we use as part of a broader, evidence-based approach to knee osteoarthritis care, alongside PRP injections, corticosteroid injections, and surgical options when appropriate.
Helps lubricate the knee joint and supports smoother movement
Meaningfully reduce pain and stiffness for appropriate candidates
Injected directly into the knee joint by a physician
Typically given as a short series of weekly injections per treatment cycle
WHY PATIENTS CHOOSE GENVISC® 850
Care Built Around Your Coverage and Your Timeline
Our board-certified orthopedic specialists evaluate every patient individually before recommending GenVisc® 850, and help you choose the path that fits your situation.
Non-Surgical Option
A non-surgical step for appropriate candidates with knee osteoarthritis, before considering joint replacement.
Physician-Administered
Every injection is performed by an Elite Ortho physician — never delegated to outside staff.
Two Ways to Start
Use your insurance, or ask about our self-pay Direct Access path — whichever fits your timeline.
Evidence-Based
Supported by 30+ published clinical studies on hyaluronic acid viscosupplementation.
2–3 wks
Direct Rx Access
vs
6–12 wks
Insurance Approval Wait
Side-by-Side Comparison
Insurance Path vs. Self-Pay Direct Access
Most patients use insurance, and our team handles prior authorization on your behalf. For patients who are uninsured, have a high deductible, or want to avoid the prior-authorization timeline, we also offer a self-pay path with transparent, fixed pricing. We'll help you choose — neither path is the "wrong" one.
Traditional Insurance
We submit prior authorization and manage the claims process for you
Typical turnaround: about 6–12 weeks
Cost depends on your plan, deductible, and coverage
Best when your plan covers HA injections and timing isn't urgent
Direct Rx Program
Recommended
No prior-authorization step — we verify eligibility and proceed
Typical turnaround: about 2–3 weeks
Transparent, fixed out-of-pocket pricing, confirmed before treatment
Best for uninsured patients, high deductibles, or insurance delays
How It Works
Four Steps From Consultation to Relief
Treatment timing depends on the path you choose — typically 2–3 weeks for self-pay Direct Access, or 6–12 weeks while insurance prior authorization is processed.
Consultation
A board-certified orthopedic provider confirms your diagnosis and discusses whether GenVisc® 850 is right for you.
Payment
We check your insurance benefits or walk you through self-pay pricing, so you know your path and cost upfront.
Medication Shipped
Once confirmed, GenVisc® 850 is ordered and delivered to our clinic ahead of your visit.
Injection Scheduled
You'll receive your injection series on-site with one of our physicians, plus a follow-up and activity plan.
Treatment timelines vary by path and individual eligibility. Your care team will confirm your specific schedule.
Clinical Evidence
Proven. Safe. Effective.
Proven
Supported by 30+ clinical studies
Long-term efficacy demonstrated
Peer-reviewed published data
Safe
Non-avian source
Used in repeat treatment cycles for appropriate candidates
Side effects are generally mild and temporary
Effective
Many patients report meaningful pain reduction
Benefit may last several months for appropriate candidates
Delays or avoids surgery for many
30+
Clinical Studies
3–5
Weekly Injections
2–3
Weeks to Access
100%
Non-Surgical
Individual results vary. GenVisc® 850 is not a substitute for surgery in advanced osteoarthritis — your provider will confirm what's appropriate for your diagnosis.
Who Qualifies?
Is This Program Right for You?
GenVisc® 850 is often considered for patients who've been diagnosed with knee osteoarthritis and want a non-surgical option — whether they're working through insurance or paying out of pocket. Your Elite Ortho provider will confirm candidacy with an in-person evaluation.
Patients with knee osteoarthritis
Uninsured or high-deductible patients
Denied or delayed by insurance
Failed conservative treatments
Experiencing insurance delays
Medicare / Medicaid patients
Start Today
Start Your GenVisc® 850 Treatment
Whether you'd like to use your insurance or explore self-pay Direct Access, the Elite Ortho team can walk you through both options and get you scheduled.
No Authorization
Physician-Administered
2–3 Week Access
Clinically Proven
Contact us
Let’s Get You Scheduled
Speak directly with our team to schedule your appointment at the time that works best for you.
Mon–Fri: 8:30 AM – 5:00 PM
(301)-851-0776
